Market Analysis and Insights: Global Gastrointestinal Therapeutics Market
The research report studies the Gastrointestinal Therapeutics market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
The global Gastrointestinal Therapeutics market size is projected to reach US$ 50460 million by 2027, from US$ 34130 million in 2020, at a CAGR of 5.3% during 2021-2027.
Global Gastrointestinal Therapeutics Scope and Segment
The global Gastrointestinal Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gastrointestinal Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
by Type, the market is primarily split into
Oral
Parenteral
by Application, this report covers the following segments
IBD
Irritable Bowel Syndrome (IBS)
Global Gastrointestinal Therapeutics market: regional analysis, the major regions covered in the report are:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.
The Gastrointestinal Therapeutics key players in this market include:
AbbVie
Allergan
Johnson & Johnson
Takeda
Novartis
Pfizer
Merck
F. Hoffmann-La Roche
Eli Lilly
AstraZeneca
Procter & Gamble
Tillotts Pharma
Takeda
GlaxoSmithKline
Amgen
The research report studies the Gastrointestinal Therapeutics market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
The global Gastrointestinal Therapeutics market size is projected to reach US$ 50460 million by 2027, from US$ 34130 million in 2020, at a CAGR of 5.3% during 2021-2027.
Global Gastrointestinal Therapeutics Scope and Segment
The global Gastrointestinal Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gastrointestinal Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
by Type, the market is primarily split into
Oral
Parenteral
by Application, this report covers the following segments
IBD
Irritable Bowel Syndrome (IBS)
Global Gastrointestinal Therapeutics market: regional analysis, the major regions covered in the report are:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.
The Gastrointestinal Therapeutics key players in this market include:
AbbVie
Allergan
Johnson & Johnson
Takeda
Novartis
Pfizer
Merck
F. Hoffmann-La Roche
Eli Lilly
AstraZeneca
Procter & Gamble
Tillotts Pharma
Takeda
GlaxoSmithKline
Amgen
1 Market Overview of Gastrointestinal Therapeutics
1.1 Gastrointestinal Therapeutics Market Overview
1.1.1 Gastrointestinal Therapeutics Product Scope
1.1.2 Gastrointestinal Therapeutics Market Status and Outlook
1.2 Global Gastrointestinal Therapeutics Market Size Overview by Region 2016 VS 2021VS 2027
1.3 Global Gastrointestinal Therapeutics Market Size by Region (2016-2027)
1.4 Global Gastrointestinal Therapeutics Historic Market Size by Region (2016-2021)
1.5 Global Gastrointestinal Therapeutics Market Size Forecast by Region (2022-2027)
1.6 Key Regions, Gastrointestinal Therapeutics Market Size (2016-2027)
1.6.1 North America Gastrointestinal Therapeutics Market Size (2016-2027)
1.6.2 Europe Gastrointestinal Therapeutics Market Size (2016-2027)
1.6.3 Asia-Pacific Gastrointestinal Therapeutics Market Size (2016-2027)
1.6.4 Latin America Gastrointestinal Therapeutics Market Size (2016-2027)
1.6.5 Middle East & Africa Gastrointestinal Therapeutics Market Size (2016-2027)
2 Gastrointestinal Therapeutics Market Overview by Type
2.1 Global Gastrointestinal Therapeutics Market Size by Type: 2016 VS 2021 VS 2027
2.2 Global Gastrointestinal Therapeutics Historic Market Size by Type (2016-2021)
2.3 Global Gastrointestinal Therapeutics Forecasted Market Size by Type (2022-2027)
2.4 Oral
2.5 Parenteral
3 Gastrointestinal Therapeutics Market Overview by Application
3.1 Global Gastrointestinal Therapeutics Market Size by Application: 2016 VS 2021 VS 2027
3.2 Global Gastrointestinal Therapeutics Historic Market Size by Application (2016-2021)
3.3 Global Gastrointestinal Therapeutics Forecasted Market Size by Application (2022-2027)
3.4 IBD
3.5 Irritable Bowel Syndrome (IBS)
4 Gastrointestinal Therapeutics Competition Analysis by Players
4.1 Global Gastrointestinal Therapeutics Market Size by Players (2016-2021)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gastrointestinal Therapeutics as of 2020)
4.3 Date of Key Players Enter into Gastrointestinal Therapeutics Market
4.4 Global Top Players Gastrointestinal Therapeutics Headquarters and Area Served
4.5 Key Players Gastrointestinal Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 Gastrointestinal Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 AbbVie
5.1.1 AbbVie Profile
5.1.2 AbbVie Main Business
5.1.3 AbbVie Gastrointestinal Therapeutics Products, Services and Solutions
5.1.4 AbbVie Gastrointestinal Therapeutics Revenue (US$ Million) & (2016-2021)
5.1.5 AbbVie Recent Developments
5.2 Allergan
5.2.1 Allergan Profile
5.2.2 Allergan Main Business
5.2.3 Allergan Gastrointestinal Therapeutics Products, Services and Solutions
5.2.4 Allergan Gastrointestinal Therapeutics Revenue (US$ Million) & (2016-2021)
5.2.5 Allergan Recent Developments
5.3 Johnson & Johnson
5.3.1 Johnson & Johnson Profile
5.3.2 Johnson & Johnson Main Business
5.3.3 Johnson & Johnson Gastrointestinal Therapeutics Products, Services and Solutions
5.3.4 Johnson & Johnson Gastrointestinal Therapeutics Revenue (US$ Million) & (2016-2021)
5.3.5 Takeda Recent Developments
5.4 Takeda
5.4.1 Takeda Profile
5.4.2 Takeda Main Business
5.4.3 Takeda Gastrointestinal Therapeutics Products, Services and Solutions
5.4.4 Takeda Gastrointestinal Therapeutics Revenue (US$ Million) & (2016-2021)
5.4.5 Takeda Recent Developments
5.5 Novartis
5.5.1 Novartis Profile
5.5.2 Novartis Main Business
5.5.3 Novartis Gastrointestinal Therapeutics Products, Services and Solutions
5.5.4 Novartis Gastrointestinal Therapeutics Revenue (US$ Million) & (2016-2021)
5.5.5 Novartis Recent Developments
5.6 Pfizer
5.6.1 Pfizer Profile
5.6.2 Pfizer Main Business
5.6.3 Pfizer Gastrointestinal Therapeutics Products, Services and Solutions
5.6.4 Pfizer Gastrointestinal Therapeutics Revenue (US$ Million) & (2016-2021)
5.6.5 Pfizer Recent Developments
5.7 Merck
5.7.1 Merck Profile
5.7.2 Merck Main Business
5.7.3 Merck Gastrointestinal Therapeutics Products, Services and Solutions
5.7.4 Merck Gastrointestinal Therapeutics Revenue (US$ Million) & (2016-2021)
5.7.5 Merck Recent Developments
5.8 F. Hoffmann-La Roche
5.8.1 F. Hoffmann-La Roche Profile
5.8.2 F. Hoffmann-La Roche Main Business
5.8.3 F. Hoffmann-La Roche Gastrointestinal Therapeutics Products, Services and Solutions
5.8.4 F. Hoffmann-La Roche Gastrointestinal Therapeutics Revenue (US$ Million) & (2016-2021)
5.8.5 F. Hoffmann-La Roche Recent Developments
5.9 Eli Lilly
5.9.1 Eli Lilly Profile
5.9.2 Eli Lilly Main Business
5.9.3 Eli Lilly Gastrointestinal Therapeutics Products, Services and Solutions
5.9.4 Eli Lilly Gastrointestinal Therapeutics Revenue (US$ Million) & (2016-2021)
5.9.5 Eli Lilly Recent Developments
5.10 AstraZeneca
5.10.1 AstraZeneca Profile
5.10.2 AstraZeneca Main Business
5.10.3 AstraZeneca Gastrointestinal Therapeutics Products, Services and Solutions
5.10.4 AstraZeneca Gastrointestinal Therapeutics Revenue (US$ Million) & (2016-2021)
5.10.5 AstraZeneca Recent Developments
5.11 Procter & Gamble
5.11.1 Procter & Gamble Profile
5.11.2 Procter & Gamble Main Business
5.11.3 Procter & Gamble Gastrointestinal Therapeutics Products, Services and Solutions
5.11.4 Procter & Gamble Gastrointestinal Therapeutics Revenue (US$ Million) & (2016-2021)
5.11.5 Procter & Gamble Recent Developments
5.12 Tillotts Pharma
5.12.1 Tillotts Pharma Profile
5.12.2 Tillotts Pharma Main Business
5.12.3 Tillotts Pharma Gastrointestinal Therapeutics Products, Services and Solutions
5.12.4 Tillotts Pharma Gastrointestinal Therapeutics Revenue (US$ Million) & (2016-2021)
5.12.5 Tillotts Pharma Recent Developments
5.13 Takeda
5.13.1 Takeda Profile
5.13.2 Takeda Main Business
5.13.3 Takeda Gastrointestinal Therapeutics Products, Services and Solutions
5.13.4 Takeda Gastrointestinal Therapeutics Revenue (US$ Million) & (2016-2021)
5.13.5 Takeda Recent Developments
5.14 GlaxoSmithKline
5.14.1 GlaxoSmithKline Profile
5.14.2 GlaxoSmithKline Main Business
5.14.3 GlaxoSmithKline Gastrointestinal Therapeutics Products, Services and Solutions
5.14.4 GlaxoSmithKline Gastrointestinal Therapeutics Revenue (US$ Million) & (2016-2021)
5.14.5 GlaxoSmithKline Recent Developments
5.15 Amgen
5.15.1 Amgen Profile
5.15.2 Amgen Main Business
5.15.3 Amgen Gastrointestinal Therapeutics Products, Services and Solutions
5.15.4 Amgen Gastrointestinal Therapeutics Revenue (US$ Million) & (2016-2021)
5.15.5 Amgen Recent Developments
6 North America
6.1 North America Gastrointestinal Therapeutics Market Size by Country (2016-2027)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Gastrointestinal Therapeutics Market Size by Country (2016-2027)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Gastrointestinal Therapeutics Market Size by Region (2016-2027)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Gastrointestinal Therapeutics Market Size by Country (2016-2027)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Gastrointestinal Therapeutics Market Size by Country (2016-2027)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Gastrointestinal Therapeutics Market Dynamics
11.1 Gastrointestinal Therapeutics Industry Trends
11.2 Gastrointestinal Therapeutics Market Drivers
11.3 Gastrointestinal Therapeutics Market Challenges
11.4 Gastrointestinal Therapeutics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
1.1 Gastrointestinal Therapeutics Market Overview
1.1.1 Gastrointestinal Therapeutics Product Scope
1.1.2 Gastrointestinal Therapeutics Market Status and Outlook
1.2 Global Gastrointestinal Therapeutics Market Size Overview by Region 2016 VS 2021VS 2027
1.3 Global Gastrointestinal Therapeutics Market Size by Region (2016-2027)
1.4 Global Gastrointestinal Therapeutics Historic Market Size by Region (2016-2021)
1.5 Global Gastrointestinal Therapeutics Market Size Forecast by Region (2022-2027)
1.6 Key Regions, Gastrointestinal Therapeutics Market Size (2016-2027)
1.6.1 North America Gastrointestinal Therapeutics Market Size (2016-2027)
1.6.2 Europe Gastrointestinal Therapeutics Market Size (2016-2027)
1.6.3 Asia-Pacific Gastrointestinal Therapeutics Market Size (2016-2027)
1.6.4 Latin America Gastrointestinal Therapeutics Market Size (2016-2027)
1.6.5 Middle East & Africa Gastrointestinal Therapeutics Market Size (2016-2027)
2 Gastrointestinal Therapeutics Market Overview by Type
2.1 Global Gastrointestinal Therapeutics Market Size by Type: 2016 VS 2021 VS 2027
2.2 Global Gastrointestinal Therapeutics Historic Market Size by Type (2016-2021)
2.3 Global Gastrointestinal Therapeutics Forecasted Market Size by Type (2022-2027)
2.4 Oral
2.5 Parenteral
3 Gastrointestinal Therapeutics Market Overview by Application
3.1 Global Gastrointestinal Therapeutics Market Size by Application: 2016 VS 2021 VS 2027
3.2 Global Gastrointestinal Therapeutics Historic Market Size by Application (2016-2021)
3.3 Global Gastrointestinal Therapeutics Forecasted Market Size by Application (2022-2027)
3.4 IBD
3.5 Irritable Bowel Syndrome (IBS)
4 Gastrointestinal Therapeutics Competition Analysis by Players
4.1 Global Gastrointestinal Therapeutics Market Size by Players (2016-2021)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gastrointestinal Therapeutics as of 2020)
4.3 Date of Key Players Enter into Gastrointestinal Therapeutics Market
4.4 Global Top Players Gastrointestinal Therapeutics Headquarters and Area Served
4.5 Key Players Gastrointestinal Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 Gastrointestinal Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 AbbVie
5.1.1 AbbVie Profile
5.1.2 AbbVie Main Business
5.1.3 AbbVie Gastrointestinal Therapeutics Products, Services and Solutions
5.1.4 AbbVie Gastrointestinal Therapeutics Revenue (US$ Million) & (2016-2021)
5.1.5 AbbVie Recent Developments
5.2 Allergan
5.2.1 Allergan Profile
5.2.2 Allergan Main Business
5.2.3 Allergan Gastrointestinal Therapeutics Products, Services and Solutions
5.2.4 Allergan Gastrointestinal Therapeutics Revenue (US$ Million) & (2016-2021)
5.2.5 Allergan Recent Developments
5.3 Johnson & Johnson
5.3.1 Johnson & Johnson Profile
5.3.2 Johnson & Johnson Main Business
5.3.3 Johnson & Johnson Gastrointestinal Therapeutics Products, Services and Solutions
5.3.4 Johnson & Johnson Gastrointestinal Therapeutics Revenue (US$ Million) & (2016-2021)
5.3.5 Takeda Recent Developments
5.4 Takeda
5.4.1 Takeda Profile
5.4.2 Takeda Main Business
5.4.3 Takeda Gastrointestinal Therapeutics Products, Services and Solutions
5.4.4 Takeda Gastrointestinal Therapeutics Revenue (US$ Million) & (2016-2021)
5.4.5 Takeda Recent Developments
5.5 Novartis
5.5.1 Novartis Profile
5.5.2 Novartis Main Business
5.5.3 Novartis Gastrointestinal Therapeutics Products, Services and Solutions
5.5.4 Novartis Gastrointestinal Therapeutics Revenue (US$ Million) & (2016-2021)
5.5.5 Novartis Recent Developments
5.6 Pfizer
5.6.1 Pfizer Profile
5.6.2 Pfizer Main Business
5.6.3 Pfizer Gastrointestinal Therapeutics Products, Services and Solutions
5.6.4 Pfizer Gastrointestinal Therapeutics Revenue (US$ Million) & (2016-2021)
5.6.5 Pfizer Recent Developments
5.7 Merck
5.7.1 Merck Profile
5.7.2 Merck Main Business
5.7.3 Merck Gastrointestinal Therapeutics Products, Services and Solutions
5.7.4 Merck Gastrointestinal Therapeutics Revenue (US$ Million) & (2016-2021)
5.7.5 Merck Recent Developments
5.8 F. Hoffmann-La Roche
5.8.1 F. Hoffmann-La Roche Profile
5.8.2 F. Hoffmann-La Roche Main Business
5.8.3 F. Hoffmann-La Roche Gastrointestinal Therapeutics Products, Services and Solutions
5.8.4 F. Hoffmann-La Roche Gastrointestinal Therapeutics Revenue (US$ Million) & (2016-2021)
5.8.5 F. Hoffmann-La Roche Recent Developments
5.9 Eli Lilly
5.9.1 Eli Lilly Profile
5.9.2 Eli Lilly Main Business
5.9.3 Eli Lilly Gastrointestinal Therapeutics Products, Services and Solutions
5.9.4 Eli Lilly Gastrointestinal Therapeutics Revenue (US$ Million) & (2016-2021)
5.9.5 Eli Lilly Recent Developments
5.10 AstraZeneca
5.10.1 AstraZeneca Profile
5.10.2 AstraZeneca Main Business
5.10.3 AstraZeneca Gastrointestinal Therapeutics Products, Services and Solutions
5.10.4 AstraZeneca Gastrointestinal Therapeutics Revenue (US$ Million) & (2016-2021)
5.10.5 AstraZeneca Recent Developments
5.11 Procter & Gamble
5.11.1 Procter & Gamble Profile
5.11.2 Procter & Gamble Main Business
5.11.3 Procter & Gamble Gastrointestinal Therapeutics Products, Services and Solutions
5.11.4 Procter & Gamble Gastrointestinal Therapeutics Revenue (US$ Million) & (2016-2021)
5.11.5 Procter & Gamble Recent Developments
5.12 Tillotts Pharma
5.12.1 Tillotts Pharma Profile
5.12.2 Tillotts Pharma Main Business
5.12.3 Tillotts Pharma Gastrointestinal Therapeutics Products, Services and Solutions
5.12.4 Tillotts Pharma Gastrointestinal Therapeutics Revenue (US$ Million) & (2016-2021)
5.12.5 Tillotts Pharma Recent Developments
5.13 Takeda
5.13.1 Takeda Profile
5.13.2 Takeda Main Business
5.13.3 Takeda Gastrointestinal Therapeutics Products, Services and Solutions
5.13.4 Takeda Gastrointestinal Therapeutics Revenue (US$ Million) & (2016-2021)
5.13.5 Takeda Recent Developments
5.14 GlaxoSmithKline
5.14.1 GlaxoSmithKline Profile
5.14.2 GlaxoSmithKline Main Business
5.14.3 GlaxoSmithKline Gastrointestinal Therapeutics Products, Services and Solutions
5.14.4 GlaxoSmithKline Gastrointestinal Therapeutics Revenue (US$ Million) & (2016-2021)
5.14.5 GlaxoSmithKline Recent Developments
5.15 Amgen
5.15.1 Amgen Profile
5.15.2 Amgen Main Business
5.15.3 Amgen Gastrointestinal Therapeutics Products, Services and Solutions
5.15.4 Amgen Gastrointestinal Therapeutics Revenue (US$ Million) & (2016-2021)
5.15.5 Amgen Recent Developments
6 North America
6.1 North America Gastrointestinal Therapeutics Market Size by Country (2016-2027)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Gastrointestinal Therapeutics Market Size by Country (2016-2027)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Gastrointestinal Therapeutics Market Size by Region (2016-2027)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Gastrointestinal Therapeutics Market Size by Country (2016-2027)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Gastrointestinal Therapeutics Market Size by Country (2016-2027)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Gastrointestinal Therapeutics Market Dynamics
11.1 Gastrointestinal Therapeutics Industry Trends
11.2 Gastrointestinal Therapeutics Market Drivers
11.3 Gastrointestinal Therapeutics Market Challenges
11.4 Gastrointestinal Therapeutics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
